As of the latest SEC filings, Mereo BioPharma Group plc (MREO) is held by 5 institutional funds. The largest fund shareholder is iShares Genomics Immunology and Healthcare ETF (IDNA), holding an estimated $62,440.04 in market value, representing 0.04% of its portfolio.
Funds holding Mereo BioPharma Group plc (MREO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MREO
- CIK:
- 0001719714
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
ETF | BlackRock / iShares | 0.04% | $62,440.04 | 232,638 | Apr 30, 2026 | Jun 25, 2026 |
|
GWX
State Street(R) SPDR(R) S&P(R) International Small Cap ETF
|
ETF | State Street (SPDR) | 0.01% | $44,015.07 | 133,379 | Mar 31, 2026 | May 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $34,293.10 | 92,534 | Feb 28, 2026 | Apr 24, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.09% | $34,138.60 | 127,193 | Apr 30, 2026 | Jun 22, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | $396.00 | 1,200 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)